BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18508930)

  • 1. Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.
    Ordway D; Henao-Tamayo M; Shanley C; Smith EE; Palanisamy G; Wang B; Basaraba RJ; Orme IM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1248-58. PubMed ID: 18508930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.
    Jeevan A; Bonilla DL; McMurray DN
    Immunology; 2009 Sep; 128(1 Suppl):e296-305. PubMed ID: 19016908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
    Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
    Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis.
    Ordway D; Harton M; Henao-Tamayo M; Montoya R; Orme IM; Gonzalez-Juarrero M
    J Immunol; 2006 Apr; 176(8):4931-9. PubMed ID: 16585589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.
    Ordway DJ; Shang S; Henao-Tamayo M; Obregon-Henao A; Nold L; Caraway M; Shanley CA; Basaraba RJ; Duncan CG; Orme IM
    Clin Vaccine Immunol; 2011 Sep; 18(9):1527-35. PubMed ID: 21795460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
    Fulton SA; Martin TD; Redline RW; Henry Boom W
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Cell Composition and Cytokine Expression Within Lymph Node Granulomas from BCG-Vaccinated and Non-vaccinated Cattle Experimentally Infected with Mycobacterium bovis.
    Salguero FJ; Gibson S; Garcia-Jimenez W; Gough J; Strickland TS; Vordermeier HM; Villarreal-Ramos B
    Transbound Emerg Dis; 2017 Dec; 64(6):1734-1749. PubMed ID: 27615603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.
    Buddle BM; Shu D; Parlane NA; Subharat S; Heiser A; Hewinson RG; Vordermeier HM; Wedlock DN
    Tuberculosis (Edinb); 2016 Jul; 99():120-127. PubMed ID: 27450013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.
    Thom ML; McAulay M; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B; Hope JC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1254-60. PubMed ID: 22718125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.
    Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z
    J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice.
    Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA
    Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.
    Behar SM; Carpenter SM; Booty MG; Barber DL; Jayaraman P
    Semin Immunol; 2014 Dec; 26(6):559-77. PubMed ID: 25311810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination.
    Jeevan A; Yoshimura T; Lee KE; McMurray DN
    Infect Immun; 2003 Jan; 71(1):354-64. PubMed ID: 12496185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
    J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.